CHINA First local COVID-19 patient discharged from hospital in Manzhoul City

CHINA

First local COVID-19 patient discharged from hospital in Manzhoul City

People's Daily app

11:57, December 07, 2020

(Photos: CCTV News)

The first local COVID-19 patient in Manzhouli City has recovered and was discharged from hospital on Thursday, according to the latest news from CCTV.

The border city of Manzhouli in North China’s Inner Mongolia Autonomous Region initiated its first round of nucleic acid testing for all residents on November 22 and the second round on November 27 after two new local confirmed cases of COVID-19 were reported on November 21, including one once reported earlier as an asymptomatic case, according to the city's health commission.

The first local patient was diagnosed and confirmed on November 21 and was treated in the isolation ward of Manzhouli People’s Hospital. After receiving combined treatment with Chinese and Western medicine, he gradually recovered and had no symptoms. The results of the following two consecutive nucleic acid tests were all negative.

On December 6, the patient was permitted by the national and Inner Mongolia Autonomous Region expert groups to be discharged from hospital for meeting the discharge standards. In order to further ensure the health and safety of patients, they will continue to conduct 14-day isolation management and health monitoring in the hospital.

On the same day, Manzhouli has completed the third round of citywide nucleic acid testing, and a total of 200,745 people were tested with all samples testing negative, local authorities said Sunday.

As of 7 am Sunday, the city had 24 domestically transmitted cases, two asymptomatic cases and one suspected case. Their 1,239 close contacts have been placed under medical observation.

(Compiled by Liao Yuecen)

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue